RAC Post-Market Requirements

Question 1

What is pharmacovigilance?

Accepted Answer

Monitoring drug safety after approval

Answer

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. It is a crucial post-marketing activity that involves continuously monitoring the safety of medicines once they are available to the public. This ongoing surveillance helps identify new or rare adverse reactions that may not have been detected during clinical trials.

Question 2

Which form is submitted to the FDA to report an adverse drug event?

Accepted Answer

Form FDA 3500

Answer

Form FDA 3500, also known as the MedWatch Voluntary Reporting Form, is the primary form used by healthcare professionals and consumers to report serious adverse events, product problems, or quality issues with medical products. This includes drugs, biologics, and medical devices. It is essential for the FDA's pharmacovigilance efforts to monitor product safety once on the market.

Question 3

What is the purpose of Risk Evaluation and Mitigation Strategies (REMS)?

Accepted Answer

Ensure safe use of high-risk medications

Answer

Risk Evaluation and Mitigation Strategies (REMS) are programs required by the FDA for certain high-risk medications to ensure that the benefits of the drug outweigh its risks. REMS programs can include elements like patient registries, specialized training for prescribers, or restricted distribution systems. Their primary goal is to mitigate specific serious risks and promote the safe use of these drugs.

Question 4

Which of the following is part of post-market surveillance for medical devices?

Accepted Answer

Post-market surveillance and reporting

Answer

Post-market surveillance and reporting is a critical component of medical device regulation that occurs after a device has been cleared or approved for commercial distribution. This involves ongoing monitoring of device safety and effectiveness, including adverse event reporting and analyzing performance data. These activities help identify potential problems that may not have been apparent during pre-market review.

Question 5

What is a Class I recall?

Accepted Answer

Potentially serious health risk

Answer

A Class I recall is the most serious type of recall issued by the FDA, indicating that there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. These recalls are initiated when a product poses a significant and immediate threat to public health. They require immediate action to remove the product from the market.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

RAC Post-Market Requirements